The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Elimination of HIV-1-infected cells by broadly neutralizing antibodies
Open accessAbstract
The Fc region of HIV-1 Env-specific broadly neutralizing antibodies (bNAbs) is required for suppressing viraemia, through mechanisms which remain poorly understood. Here, we identify bNAbs that exert antibody-dependent cellular cytotoxicity (ADCC) in cell culture and kill HIV-1-infected lymphocytes through natural killer (NK) engagement. These antibodies target the CD4-binding site, the glycans/V3 and V1/V2 loops on gp120, or the gp41 moiety. The landscape of Env epitope exposure at the surface and the sensitivity of infected cells to ADCC vary considerably between viral strains. Efficient ADCC requires sustained cell surface binding of bNAbs to Env, and combining bNAbs allows a potent killing activity. Furthermore, reactivated infected cells from HIV-positive individuals expose heterogeneous Env epitope patterns, with levels that are often but not always sufficient to trigger killing by bNAbs. Our study delineates the parameters controlling ADCC activity of bNAbs, and supports the use of the most potent antibodies to clear the viral reservoir.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Haynes, B. F., Gilbert, P. B., McElrath, M. J., Zolla-Pazner, S., Tomaras, G. D., Alam, S. M., Evans, D. T., Montefiori, D. C., Karnasuta, C., Sutthent, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113425 · Cited by 1,808
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Chomont, N., El-Far, M., Ancuta, P., Trautmann, L., Procopio, F. A., Yassine-Diab, B., Boucher, G., Boulassel, M.-R., Ghattas, G., Brenchley, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1972 · Cited by 1,722
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Scheid, J. F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T. Y. K., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K., et al. (2011) · Science · doi:10.1126/science.1207227 · Cited by 1,139
Self-citationFc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901
Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
Maldarelli, F., Wu, X., Su, L., Simonetti, F. R., Shao, W., Hill, S., Spindler, J., Ferris, A. L., Mellors, J. W., Kearney, M. F., et al. (2014) · Science · doi:10.1126/science.1254194 · Cited by 849
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Caskey, M., Klein, F., Lorenzi, J. C. C., Seaman, M. S., West, A. P., Buckley, N., Kremer, G., Nogueira, L., Braunschweig, M., Scheid, J. F., et al. (2015) · Nature · doi:10.1038/nature14411 · Cited by 767
Salazar-Gonzalez, J. F., Salazar, M. G., Keele, B. F., Learn, G. H., Giorgi, E. E., Li, H., Decker, J. M., Wang, S., Baalwa, J., Kraus, M. H., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090378 · Cited by 764
Shan, L., Deng, K., Shroff, N. S., Durand, C. M., Rabi, S. A., Yang, H.-C., Zhang, H., Margolick, J. B., Blankson, J. N., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.014 · Cited by 714
Seaman, M. S., Janes, H., Hawkins, N., Grandpre, L. E., Devoy, C., Giri, A., Coffey, R. T., Harris, L., Wood, B., Daniels, M. G., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02108-09 · Cited by 632
Towards an HIV cure: a global scientific strategy
The International AIDS Society Scientific Working Group on HIV Cure (2012) · Nature Reviews Immunology · doi:10.1038/nri3262 · Cited by 554
Complex-type N -glycan recognition by potent broadly neutralizing HIV antibodies
Mouquet, H., Scharf, L., Euler, Z., Liu, Y., Eden, C., Scheid, J. F., Halper-Stromberg, A., Gnanapragasam, P. N. P., Spencer, D. I. R., Seaman, M. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217207109 · Cited by 550
Self-citationHIV-1 neutralizing antibodies induced by native-like envelope trimers
Sanders, R. W., van Gils, M. J., Derking, R., Sok, D., Ketas, T. J., Burger, J. A., Ozorowski, G., Cupo, A., Simonich, C., Goo, L., et al. (2015) · Science · doi:10.1126/science.aac4223 · Cited by 496
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Bournazos, S., Klein, F., Pietzsch, J., Seaman, M. S., Nussenzweig, M. C., & Ravetch, J. V. (2014) · Cell · doi:10.1016/j.cell.2014.08.023 · Cited by 493
Antibodies in HIV-1 Vaccine Development and Therapy
Klein, F., Mouquet, H., Dosenovic, P., Scheid, J. F., Scharf, L., & Nussenzweig, M. C. (2013) · Science · doi:10.1126/science.1241144 · Cited by 457
Self-citationHIV-1 Integration Landscape during Latent and Active Infection
Cohn, L. B., Silva, I. T., Oliveira, T. Y., Rosales, R. A., Parrish, E. H., Learn, G. H., Hahn, B. H., Czartoski, J. L., McElrath, M. J., Lehmann, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.020 · Cited by 444
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
Stamatatos, L., Morris, L., Burton, D. R., & Mascola, J. R. (2009) · Nature Medicine · doi:10.1038/nm.1949 · Cited by 430
Antibody responses to envelope glycoproteins in HIV-1 infection
Burton, D. R., & Mascola, J. R. (2015) · Nature Immunology · doi:10.1038/ni.3158 · Cited by 385
Enhanced neonatal Fc receptor function improves protection against primate SHIV infection
Ko, S.-Y., Pegu, A., Rudicell, R. S., Yang, Z.-Y., Joyce, M. G., Chen, X., Wang, K., Bao, S., Kraemer, T. D., Rath, T., et al. (2014) · Nature · doi:10.1038/nature13612 · Cited by 384
Halper-Stromberg, A., Lu, C.-L., Klein, F., Horwitz, J. A., Bournazos, S., Nogueira, L., Eisenreich, T. R., Liu, C., Gazumyan, A., Schaefer, U., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.043 · Cited by 381
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
Chung, A. W., Kumar, M. P., Arnold, K. B., Yu, W. H., Schoen, M. K., Dunphy, L. J., Suscovich, T. J., Frahm, N., Linde, C., Mahan, A. E., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.027 · Cited by 352
Ochsenbauer, C., Edmonds, T. G., Ding, H., Keele, B. F., Decker, J., Salazar, M. G., Salazar-Gonzalez, J. F., Shattock, R., Haynes, B. F., Shaw, G. M., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06157-11 · Cited by 342
Lambotte, O., Ferrari, G., Moog, C., Yates, N. L., Liao, H.-X., Parks, R. J., Hicks, C. B., Owzar, K., Tomaras, G. D., Montefiori, D. C., et al. (2009) · AIDS · doi:10.1097/qad.0b013e328329f97d · Cited by 342
Self-citationAn Integrated Overview of HIV-1 Latency
Ruelas, D. S., & Greene, W. C. (2013) · Cell · doi:10.1016/j.cell.2013.09.044 · Cited by 324
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
Barouch, D. H., Alter, G., Broge, T., Linde, C., Ackerman, M. E., Brown, E. P., Borducchi, E. N., Smith, K. M., Nkolola, J. P., Liu, J., et al. (2015) · Science · doi:10.1126/science.aab3886 · Cited by 297
Maldarelli, F., Wu, X., Su, L., Simonetti, F., Wells, D., Shao, W., Spindler, J., Ferris, A., Mellors, J., Kearney, M., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000479721.09749.2d · Cited by 294
Tobin, N. H., Learn, G. H., Holte, S. E., Wang, Y., Melvin, A. J., McKernan, J. L., Pawluk, D. M., Mohan, K. M., Lewis, P. F., Mullins, J. I., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9625-9634.2005 · Cited by 217
Towards an HIV-1 cure: measuring the latent reservoir
Bruner, K. M., Hosmane, N. N., & Siliciano, R. F. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.01.013 · Cited by 185
Tetherin Restricts Productive HIV-1 Cell-to-Cell Transmission
Casartelli, N., Sourisseau, M., Feldmann, J., Guivel‐Benhassine, F., Mallet, A., Marcelin, A., Guatelli, J., & Schwartz, O. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000955 · Cited by 168
Self-citationBroadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission
Malbec, M., Porrot, F., Rua, R., Horwitz, J., Klein, F., Halper-Stromberg, A., Scheid, J. F., Eden, C., Mouquet, H., Nussenzweig, M. C., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20131244 · Cited by 166
Self-citationImmune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure
Chung, A. W., Isitman, G., Navis, M., Kramski, M., Kent, S. J., & Stratov, I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016048108 · Cited by 157
CD4 mimetics sensitize HIV-1-infected cells to ADCC
Richard, J., Veillette, M., Brassard, N., Iyer, S. S., Roger, M., Martin, L., Pazgier, M., Schön, A., Freire, E., Routy, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506755112 · Cited by 150
Neutralizing antibodies to HIV-1 induced by immunization
McCoy, L. E., & Weiss, R. A. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121827 · Cited by 140
Kong, R., Louder, M. K., Wagh, K., Bailer, R. T., deCamp, A. C., Greene, K., Gao, H., Taft, J. D., Gazumyan, A., Liu, C., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03136-14 · Cited by 135
Antibody B cell responses in HIV-1 infection
Mouquet, H. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.08.007 · Cited by 131
Self-citationMilligan, C., Richardson, B. A., John-Stewart, G. C., Nduati, R. W., & Overbaugh, J. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.002 · Cited by 126
Pham, T. N. Q., Lukhele, S., Hajjar, F., Routy, J., & Cohen, É. A. (2014) · Retrovirology · doi:10.1186/1742-4690-11-15 · Cited by 116
Memory B Cell Antibodies to HIV-1 gp140 Cloned from Individuals Infected with Clade A and B Viruses
Mouquet, H., Klein, F., Scheid, J. F., Warncke, M. L., Pietzsch, J., Oliveira, T. Y., Velinzon, K., Seaman, M. S., & Nussenzweig, M. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024078 · Cited by 111
Self-citationSmalls-Mantey, A., Doria‐Rose, N. A., Klein, R. M., Patamawenu, A. A., Migueles, S. A., Ko, S., Hallahan, C. W., Wong, H. C., Liu, B., You, L., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00287-12 · Cited by 110
Activation and lysis of human CD4 cells latently infected with HIV-1
Pegu, A., Asokan, M., Wu, L., Wang, K., Hataye, J. M., Casazza, J. P., Guo, X., Shi, W., Georgiev, I. S., Zhou, T., et al. (2015) · Nature Communications · doi:10.1038/ncomms9447 · Cited by 100
Reh, L., Magnus, C., Schanz, M., Weber, J., Uhr, T., Rusert, P., & Trkola, A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004966 · Cited by 94
Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir
Chun, T., Murray, D., Justement, J. S., Blažková, J., Hallahan, C. W., Fankuchen, O., Gittens, K. R., Benko, E., Kovacs, C. M., Moir, S. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414148111 · Cited by 72
Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells
Lee, W. S., Richard, J., Lichtfuss, M., Smith, A. B., Park, J., Courter, J. R., Melillo, B. N., Sodroski, J., Kaufmann, D., Finzi, A., et al. (2015) · Journal of Virology · doi:10.1128/jvi.02717-15 · Cited by 56
Exploring the Potential of Monoclonal Antibody Therapeutics for HIV-1 Eradication
Euler, Z., & Alter, G. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0235 · Cited by 46
Kramski, M., Stratov, I., & Kent, S. J. (2014) · AIDS · doi:10.1097/qad.0000000000000523 · Cited by 38
Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?
Lee, W. S., Parsons, M. S., Kent, S. J., & Lichtfuss, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00265 · Cited by 27
Cited by
Beyond binding: antibody effector functions in infectious diseases
Lu, L. L., Suscovich, T. J., Fortune, S. M., & Alter, G. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.106 · Cited by 825
Microglial Cells: The Main HIV-1 Reservoir in the Brain
Wallet, C., De Rovere, M., Van Assche, J., Daouad, F., De Wit, S., Gautier, V., Mallon, P. W. G., Marcello, A., Van Lint, C., Rohr, O., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00362 · Cited by 368
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
Dufloo, J., Grzelak, L., Staropoli, I., Madec, Y., Tondeur, L., Anna, F., Pelleau, S., Wiedemann, A., Planchais, C., Buchrieser, J., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100275 · Cited by 89
Self-citationHIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Dufloo, J., Bruel, T., & Schwartz, O. (2018) · Retrovirology · doi:10.1186/s12977-018-0434-1 · Cited by 69
Self-citationSáez-Cirión, A., Mamez, A.-C., Avettand-Fenoel, V., Nabergoj, M., Passaes, C., Thoueille, P., Decosterd, L., Hentzien, M., Perdomo-Celis, F., Salgado, M., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03277-z · Cited by 57
Self-citation
Metadata
- Authors
- Bruel, T., Guivel-Benhassine, F., Amraoui, S., Malbec, M., Richard, L., Bourdic, K., Donahue, D. A., Lorin, V., Casartelli, N., Noël, N., Lambotte, O., Mouquet, H., & Schwartz, O.
- Venue
- Nature Communications
- Published
- 2016-03-03
- Volume
- 7
- Issue
- 1
- Pages
- 10844-10844
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2330954981
- Cited by
- 271
- References
- 45
- FWCI
- 24.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.